Table 1.
The main events that occurred during the patient’s illness and the lab values of some important tests obtained at each corresponding event.
| Time | Event | ALT (U/L) | AST (U/L) | Total bilirubin (mg/dL) | Direct bilirubin (mg/dL) | Indirect bilirubin (mg/dL) | INR | Na (mmol/L) | K (mmol/L) | Urea (mg/dL) | Creatinine (mg/dL) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | Lab diagnosis of hepatitis A | Not available | |||||||||
| 36 days | Symptomatic manifestations of hepatitis A | Not available | |||||||||
| 70 days | Admission with hyponatremia | 317 | 445 | 28.01 | 21.26 | 6.75 | 3.27 | 115 | 5.6 | 45 | 1.0 |
| 71 days | Resolution of hyponatremia and discharge | 540 | 1026 | 27.5 | 21.5 | 6.0 | 3.40 | 124 | 4.5 | 56 | 1.0 |
| 74 days | Follow-up | 350 | – | 28.1 | 16.2 | 11.9 | – | 129 | 3.7 | 37 | 1.1 |
| 76 days | Admission with hepatorenal syndrome | – | – | – | – | – | – | 131 | 3.5 | 92 | 3.6 |
| 81 days | Start of terlipressin treatment | 40 | 100 | 29.5 | 25 | 4.5 | 5.55 | 133 | 4.0 | 173 | 4.5 |
| 84 days | Development of hepatic encephalopathy and diagnosis of subacute hepatic failure | 41 | 113 | 27.9 | – | – | 4.04 | 134 | 3.4 | 170 | 3.9 |
| 87 days | Right before death | – | – | 30.75 | 10.26 | 20.49 | 5.03 | 138 | 4.4 | 182 | 3.58 |
ALT: alanine transaminase; AST: aspartate transaminase; INR: international normalized ratio.